Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yestar Healthcare Holdings CoHKSE:02393 +4.55% EV-to-FCF is 2.12 as of Sep. 21, 2026, which is 65% below its 10-year median of 6.00. The stock has 4 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Yestar Healthcare Holdings Co ranks better than 96.17% on this metric.
The historical rank and industry rank for Yestar Healthcare Holdings Co's EV-to-FCF or its related term are showing as below:
HKSE:02393'
s EV-to-FCF Range Over the Past 10 Years
Min: -24.29 Med: 6 Max: 50.41
Current: 2.12
During the past 13 years, the highest EV-to-FCF of Yestar Healthcare Holdings Co was 50.41. The lowest was -24.29. And the median was 6.00.
HKSE:02393's EV-to-FCF is ranked better than 96.17% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 23.305
vs HKSE:02393: 2.12
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Yestar Healthcare Holdings Co (HKSE:02393) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Yestar Healthcare Holdings Co's PE Ratio (TTM) for today is calculated as:
Yestar Healthcare Holdings Co's share price for today is HK$0.069.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yestar Healthcare Holdings Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Yestar Healthcare Holdings Co EV-to-FCF Related Terms
Yestar Healthcare Holdings Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Yestar Healthcare Holdings Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yestar Healthcare Holdings Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Yestar Healthcare Holdings Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Yestar Healthcare Holdings Co's EV-to-FCF falls into.
Yestar Healthcare Holdings Co's current Enterprise Value is HK$201 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Yestar Healthcare Holdings Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yestar Healthcare Holdings Co (HKSE:02393) has a EV-to-FCF of 2.12 as of Sep. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Yestar Healthcare Holdings Co and its competitors. This is 65% below median its historical median of 6.00. According to the industry distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 3.8%.
Is Yestar Healthcare Holdings Co's EV-to-FCF too high?
Yestar Healthcare Holdings Co's current EV-to-FCF of 2.12 is 65% below median its 10-year median of 6.00. The Medical Devices & Instruments industry median EV-to-FCF is 23.31. Yestar Healthcare Holdings Co's value of 2.12 is 90.9% below this industry median. Based on the distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 418 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Yestar Healthcare Holdings Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Yestar Healthcare Holdings Co ranks #16 out of 418 companies for EV-to-FCF. This places Yestar Healthcare Holdings Co in the top 4% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.31. Yestar Healthcare Holdings Co's value of 2.12 is 90.9% below this benchmark. While the company's 10-year median is 6.00 vs. the industry median of 23.31, Yestar Healthcare Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.31, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yestar Healthcare Holdings Co's current EV-to-FCF of 2.12 is 90.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Yestar Healthcare Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yestar Healthcare Holdings Co's current EV-to-FCF is 2.12, which is 65% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yestar Healthcare Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Yestar Healthcare Holdings Co (HKSE:02393) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.07 — trading 38% above its estimated fair value. The current EV-to-FCF is 2.12, which is 65% below median its 10-year median of 6.00 and 90.9% below the Medical Devices & Instruments industry median of 23.31. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Yestar Healthcare Holdings Co (HKSE:02393), the current EV-to-FCF is 2.12 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yestar Healthcare Holdings Co Ltd is engaged in the manufacture, distribution, and sale of medical imaging products, distribution of In Vitro Diagnostic (IVD) products, and manufacture and sale of dental films. The Group has two reportable operating segments: Imaging printing products segment, which includes the manufacture and sale of colour photographic paper, industrial NDT x-ray films and PWB films, and trading of imaging equipment; and Medical products and equipment segment, which generates maximum revenue and includes manufacture and sale of medical dry films, medical wet films and dental films, and sale of medical equipment and diagnostic reagents. The Group operates its business in Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02393 has been successfully added to your 
